The European Medicines Agency (EMA) this week recommended granting a marketing authorization for Altuvoct (efanesoctocog alfa) for the treatment and prophylaxis of bleeding in patients with hemophilia ...

Add Yahoo as a preferred source to see more of our stories on Google. Factor V Leiden is a genetic blood clotting disorder. Hailshadow/ Getty Images Factor V Leiden is an incurable, genetic blood ...

Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. Treatment focuses on managing bleeding episode symptoms with clotting factor replacement therapy, ...

The phase 3 trial of valoctocogene roxaparvovec for severe hemophilia A showed it reduced bleeding events as well as the use of factor VIII concentrates. A phase 3 trial of valoctocogene roxaparvovec, ...

Scientists are edging closer to defeating a longtime enemy of human health: hemophilia, the inability to form blood clots. After trying for decades to develop a gene therapy to treat this disease, ...

A gene-based therapy is potentially a step closer to becoming a one-time treatment for men with hemophilia. The life-threatening genetic disorder hinders the body’s ability to form blood clots. In ...

Hemophilia is a rare and often misunderstood disease. Many people only know that it’s a blood disorder, and after that, myths and misinformation abound. So what exactly is hemophilia? Alisa Wolberg, ...

All that most laymen know about hemophilia is that it is an odd and dangerous disease of the blood that strikes men only, although it is transmitted by women. Medical researchers have learned a great ...

Dear Dr. Roach • I am 80 years old and just had a stroke. I was put on Coumadin. I also had a miscarriage at age 30 with severe hemorrhaging. I think I needed a transfusion. They told me I have a ...